info@seagull-health.com
SeagullHealth
语言:
search

How should I use Vonjo(Pacritinib)?

The standard dosing involves twice-daily oral administration, with specific adjustments required for certain patient populations and adverse reactions.

How should I use Vonjo(Pacritinib)?

The recommended dosage of VONJO is 200 mg taken orally twice daily, which can be administered with or without food. Capsules must be swallowed whole. For patients with severe hepatic impairment (Child-Pugh C), the initial dosage should be reduced to 100 mg twice daily, with a potential increase to the standard dose after 12 weeks if there is no efficacy and safety concerns permit. Dose interruptions, reductions, or discontinuations are mandated for managing adverse events such as significant hemorrhage, diarrhea, thrombocytopenia, and QT interval prolongation.

Pacritinib(Vonjo)
Pacritinib(Vonjo)
Treatment of intermediate or high-risk primary or secondary myelofibrosis in...
WeChat Scan
Free Inquiry
Related articles
How to Use Vonjo (Pacritinib)
Vonjo (pacritinib) is an oral kinase inhibitor approved by the U.S. FDA in 2022. It is specifically indicated for the treatment of adult patients with intermediate- or high-risk primary or secondary (...
共 1 条
  • 1
前往
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved